Clinical Trials Browser

Phase 1 × Inflammatory Breast Neoplasms × olaparib × Clear all

NCT02227082 2021-08-04

Olaparib and Radiotherapy in Inoperable Breast Cancer

Phase 1 Completed

Breast Neoplasms, Inflammatory Breast Neoplasms